Lignans are the main active components of Schisandrae Chinensis Fructus for liver disease treatment: a review by Ke Fu, Shu Dai, Cheng Ma, Yafang Zhang, Shenglin Zhang, Cheng Wang, Lihong Gong, Honglin Zhou, Yunxia Li

“…Therefore, in the present work, we first determined the effectiveness of SC in the treatment of liver diseases such as metabolic associated fatty liver disease, alcoholic liver disease, cholestatic liver disease and acute liver injury. …”
Get full text

Effect of Ginkgolide B on Non-Alcoholic Fatty Liver Disease based on Notch Signaling Pathway by Hong YU, Junzi WU, Bo SONG, Jun LI

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Effects of laparoscopic sleeve gastrectomy on nonalcoholic fatty liver disease and TGF-β signaling pathway by Hideki Kumagai, Akira Sasaki, Akira Umemura, Keisuke Kakisaka, Takeshi Iwaya, Satoshi S Nishizuka

Subjects: “…nonalcoholic fatty liver disease (nafld)…”
Get full text

Insulin Resistance Mediates the Association Between Vitamin D and Non-Alcoholic Fatty Liver Disease by Caiyan Zou, Xuekui Liu, Maosheng He, Yan Sun, Yiquan Sang, Gangshan Peng, Yamei Ma, Houfa Geng, Jun Liang

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

The validity of serum autotaxin as a predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease by Muhammad Abdel-Gawad, Hamdiy Mahfouz, Mona Abdelmeguid, Gehad M.A.-A. Hassan, Marwa Khalaf, Hani S. Aboalam

Subjects: Get full text

The impact of fasting on cardiovascular risk control in patients with metabolic dysfunction-associated steatotic liver disease by Anna E. Płatek, Julia A. Szymańska

Subjects: “…nonalcoholic fatty liver disease…”
Get full text

Protein tyrosine phosphatase delta is a STAT3-phosphatase and suppressor of metabolic liver disease by Thomas F Baumert, Charlotte Bach, Patrick Pessaux, Catherine Schuster, Frank Jühling, Sarah C Durand, Yujin Hoshida, Fabien Zoulim, Atish Mukherji, Naoto Fujiwara, Marine A Oudot, Armando Andres Roca Suarez, Michel L Tremblay, Barbara Testoni, Joachim Lupberger, Romain Parent, Laurent Mailly, Nassim Dali-Youcef, Emanuele Felli, Maria Saez-Palma, Julien Moehlin, Alessia Virzì, Nicolas Brignon, Eugenie Schaeffer, Romain Martin, Laura Meiss-Heydmann, Zakaria Boulahtouf, Lea Girard, Emma Osswald, Carole Jamey, Daniel Brumaru, Bhuvaneswari Koneru

“…Hepatic PTPRD expression is impaired in aetiologies of chronic liver diseases that are associated with metabolic disease. …”
Get full text

Supplementation with Alpha-Tocopherol and Ascorbic Acid to Nonalcoholic Fatty Liver Disease’s Statin Therapy in Men by Nikola Hadzi-Petrushev, Katerina Dimovska, Nikola Jankulovski, Dine Mitrov, Mitko Mladenov

“…Oxidative stress and inflammation contribute to the pathogenesis and progression of nonalcoholic fatty liver disease (NAFLD), and the control of lipid status by statins may help to stop the progression of NAFLD. …”
Get full text

Diagnostic Value of the 13C Methacetin Breath Test in Various Stages of Chronic Liver Disease by Hamizah Razlan, Nurhayaty Muhamad Marzuki, Mei-Ling Sharon Tai, Azhar-Shah Shamsul, Tze-Zen Ong, Sanjiv Mahadeva

“…The accuracy of the 13C-methacetin breath test (13C-MBT) in differentiating between various stages of liver disease is not clear. A cross-sectional study of Asian patients was conducted to examine the predictive value of the 13C-MBT in various stages of chronic liver diseases. …”
Get full text

Risk of Cirrhosis in Patients with Non-alcoholic Fatty Liver Disease and Previous Viral Hepatitis B by S. N. Batskikh, E. V. Vinnitskaya, E. S. Sbikina, Zh. V. Borunova, A. S. Dorofeev, Yu. G. Sandler

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Performance of Noninvasive Indices for Discrimination of Metabolic Dysfunction-Associated Steatotic Liver Disease in Young Adults by Jaejun Lee, Chang In Han, Dong Yeup Lee, Pil Soo Sung, Si Hyun Bae, Hyun Yang

Subjects: “…biomarkers; fatty liver; metabolic dysfunction-associated steatotic liver disease; young adult; hepatic steatosis index…”
Get full text

Psychosocial Trauma History Negatively Impacts Liver Transplant Access in Women with Chronic Liver Disease by Katherine M. Cooper, Alessandro Colletta, Dhruval Amin, Darya M. Herscovici, Deepika Devuni

“…Trauma history is associated with reduced access to LT in women but not men with chronic liver disease. Further studies are needed to understand the impact of psychological trauma on LT access and post-LT outcomes.…”
Get full text

Single or multiple treatments with lusutrombopag in subjects with thrombocytopenia and chronic liver disease needing an invasive procedure by Davide Scalabrini, Paolo Sciuto, Cristina Felicani, Antonia Rudilosso, Pietro Andreone

Get full text

Plasma amino acid profiles of dogs with the hepatocutaneous syndrome and dogs with other chronic liver diseases by Rommaneeya Leela‐arporn, Karah Burns DeMarle, Cailin R. Heinze, Cynthia R. L. Webster

“…Abstract Background Dogs with hepatocutaneous syndrome (HCS) have marked plasma hypoaminoacidemia, but its occurrence in dogs with chronic liver diseases not associated with HCS (non‐HCS CLD) is unknown. …”
Get full text

Elevated Serum Levels of the Antiapoptotic Protein Decoy-Receptor 3 Are Associated with Advanced Liver Disease by Giorgos Bamias, Michalis Gizis, Ioanna Delladetsima, Eyfrosyni Laoudi, Spyros I. Siakavellas, Ioannis Koutsounas, Garyfallia Kaltsa, John Vlachogiannakos, Irene Vafiadis-Zouboulis, George L. Daikos, George V. Papatheodoridis, Spiros D. Ladas

“…Circulating levels of DcR3 are elevated during chronic liver disease and correlate with severity of liver damage. sDcR3 may serve as marker for liver fibrosis severity and progression to end-stage liver disease.…”
Get full text

Associations between White Blood Cell Count and the Development of Incidental Nonalcoholic Fatty Liver Disease by Goh Eun Chung, Jeong Yoon Yim, Donghee Kim, Min-Sun Kwak, Jong In Yang, Su Jin Chung, Sun Young Yang, Joo Sung Kim

“…Chronic low-grade inflammation is thought to be associated with the pathogenesis of nonalcoholic fatty liver disease (NAFLD). This study aimed to determine the association between serum white blood cell (WBC) counts and the development of incidental NAFLD. …”
Get full text

Efficacy of Physiologically Active nutrients in the Treatment of Asthenic Disorders in Patients with Chronic Diffuse Liver Diseases by M. V. Mayevskaya, M. A. Morozova, A. G. Beniashvili, V. D. Lunkov, V. T. Ivashkin

Subjects: “…chronic diffuse liver diseases…”
Get full text

Frequency Of Prolonged Qtc in Patients With Decompensated Chronic Liver Disease In A Rural Cohort Of Sindh by Adeel Ahmed, Bushra Rabbani, Muhammad Kamran, Ammarah Saeed, Jameel Ahmed

“…With decompensated chronic liver disease (DCLD) in a tertiary care hospital of Gadap town, Sindh. …”
Get full text

Effects of PCSK9 inhibitors on metabolic-associated fatty liver disease: a short review by Ewelina Jakielska, Paweł Głuszak, Marta Walczak, Wiesław Bryl

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Relevance of 3D Cholangiography and Transient Elastography to Assess Cystic Fibrosis-Associated Liver Disease? by C. Lemaitre, S. Dominique, E. Billoud, M. Eliezer, H. Montialoux, M. Quillard, G. Riachi, E. Koning, H. Morisse-Pradier, G. Savoye, C. Savoye-Collet, O. Goria

“…Cystic fibrosis-associated liver disease (CFLD) is a major cause of death. The objective of our retrospective study was to describe the relevance of magnetic resonance imaging (MRI) and liver stiffness measurement (LSM) for CFLD evaluation. …”
Get full text